PPAPDC1B/DPPL1 Antibody Blocking Peptide

• Reactivity: Hu
• Applications: AC
• Concentration: 0.2 mg/ml

PPAPDC1B/DPPL1 Antibody Blocking Peptide Summary

• Description: A blocking peptide containing 14 amino acids near the amino terminus of human PPAPDC1B.

  Source: Synthetic

  (Accession #: NP_001096029)

• Source: Synthetic
• Protein/Peptide Type: Antibody Blocking Peptide
• Gene: PLPP5
• Purity: N/A

Applications/Dilutions

• Dilutions:
  • Antibody Competition
• Application Notes: This peptide is useful as a blocking peptide for NBP1-76244.
  
  For further blocking peptide related protocol, click here.

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• Preservative: 0.02% Sodium Azide
• Concentration: 0.2 mg/ml
• Purity: N/A

Alternate Names for PPAPDC1B/DPPL1 Antibody Blocking Peptide

• diacylglycerol pyrophosphate like 1
• DPPL1
• EC 3.1.3.4
• HTPAPphosphatidate phosphatase PPAPDC1B
• phosphatidic acid phosphatase type 2 domain containing 1B
• Phosphatidic acid phosphatase type 2 domain-containing protein 1B

Background

Displays magnesium-independent phosphatidate phosphatase activity in vitro. Catalyzes the conversion ofphosphatidic acid to diacylglycerol. May be a metastatic suppressor for hepatocellular carcinoma

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: PLPP5